Hongyun Ruan

596 total citations · 1 hit paper
15 papers, 398 citations indexed

About

Hongyun Ruan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hongyun Ruan has authored 15 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hongyun Ruan's work include Pleural and Pulmonary Diseases (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Hongyun Ruan is often cited by papers focused on Pleural and Pulmonary Diseases (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Hongyun Ruan collaborates with scholars based in China, United States and Norway. Hongyun Ruan's co-authors include Yi Liu, Zong Xuefeng, Wen Lu, Yigang Zhang, Xiangjun Yang, Ru Liu, Miaomiao Zhang, Jia Liu, Yimei Du and Peng Wu and has published in prestigious journals such as Scientific Reports, Medicine and Journal of Surgical Research.

In The Last Decade

Hongyun Ruan

13 papers receiving 386 citations

Hit Papers

Obesity and hypertension 2016 2026 2019 2022 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyun Ruan China 5 119 90 83 61 54 15 398
Ya Xiao China 14 130 1.1× 79 0.9× 73 0.9× 134 2.2× 40 0.7× 46 632
Suttira Intapad United States 15 68 0.6× 77 0.9× 83 1.0× 106 1.7× 77 1.4× 29 762
Gavin Manmathan United Kingdom 4 118 1.0× 55 0.6× 46 0.6× 54 0.9× 26 0.5× 12 398
Steven Shea United States 11 203 1.7× 146 1.6× 72 0.9× 29 0.5× 89 1.6× 15 560
Anel Gómez‐García Mexico 12 61 0.5× 51 0.6× 70 0.8× 75 1.2× 25 0.5× 44 458
Hairong Zhou China 11 73 0.6× 91 1.0× 45 0.5× 53 0.9× 32 0.6× 35 333
Yating Wang China 7 85 0.7× 63 0.7× 157 1.9× 51 0.8× 26 0.5× 15 412
Cédric Gaxatte France 10 66 0.6× 34 0.4× 64 0.8× 56 0.9× 32 0.6× 25 485
Yeonjung Kim South Korea 13 60 0.5× 48 0.5× 55 0.7× 75 1.2× 26 0.5× 19 364

Countries citing papers authored by Hongyun Ruan

Since Specialization
Citations

This map shows the geographic impact of Hongyun Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyun Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyun Ruan more than expected).

Fields of papers citing papers by Hongyun Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyun Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyun Ruan. The network helps show where Hongyun Ruan may publish in the future.

Co-authorship network of co-authors of Hongyun Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyun Ruan. A scholar is included among the top collaborators of Hongyun Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyun Ruan. Hongyun Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ruan, Hongyun, et al.. (2025). Unveiling a Novel Glioblastoma Deep Molecular Profiling: Insight into the Cancer Cell Differentiation-Related Mechanisms. ACS Omega. 10(10). 10230–10250. 1 indexed citations
2.
Yuan, Ping, Jun Chen, Shang Wang, et al.. (2024). Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension. Clinical Cardiology. 47(2). 1 indexed citations
3.
Zhao, Qin‐Hua, Jun Chen, Fadong Chen, et al.. (2024). Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study. Pulmonary Circulation. 14(1). e12351–e12351. 3 indexed citations
5.
Zhao, Jing, Yunsong Li, Yang Li, et al.. (2024). Analysis of clinical characteristics of different types of lung function impaiement in TDL patients. BMC Pulmonary Medicine. 24(1). 292–292.
6.
Liu, Ling, Hongyun Ruan, Xiaoping Chen, et al.. (2024). A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension. Hypertension Research. 47(7). 1925–1933. 2 indexed citations
7.
Lin, Shuye, Hongyun Ruan, Cong Zhao, et al.. (2023). Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex. International Journal of Biological Sciences. 19(3). 832–851. 14 indexed citations
8.
Ruan, Hongyun, Yunsong Li, Yuxuan Wang, et al.. (2022). Risk factors for respiratory failure after tuberculosis-destroyed lung surgery and increased dyspnea score at 1-year follow-up. Journal of Thoracic Disease. 14(10). 3737–3747. 4 indexed citations
9.
Ruan, Hongyun, Fangchao Liu, Yunsong Li, et al.. (2022). Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment. BMC Pulmonary Medicine. 22(1). 346–346. 6 indexed citations
10.
Ruan, Hongyun, et al.. (2021). Risk factors associated with postoperative respiratory failure in tuberculous empyema patients. Medicine. 100(23). e25754–e25754. 3 indexed citations
11.
Liu, Jia, Hongyun Ruan, Miaomiao Zhang, et al.. (2019). Protective effects of Salidroside on cardiac function in mice with myocardial infarction. Scientific Reports. 9(1). 18127–18127. 37 indexed citations
12.
Ruan, Hongyun, Yigang Zhang, Ru Liu, & Xiangjun Yang. (2019). The acute effects of 30 mg vs 60 mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension. Congenital Heart Disease. 14(4). 645–650. 25 indexed citations
14.
Lu, Wen, et al.. (2016). Obesity and hypertension. Experimental and Therapeutic Medicine. 12(4). 2395–2399. 296 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026